Literature DB >> 27444931

Identifying Low-Abundance Biomarkers: Aptamer-Based Proteomics Potentially Enables More Sensitive Detection in Cardiovascular Diseases.

Anthony Gramolini1, Edward Lau2, Peter P Liu2.   

Abstract

Entities:  

Keywords:  Editorials; biomarkers; cohort studies; diagnosis; prognosis; proteomics

Mesh：

Substances：

Year:  2016        PMID： 27444931     DOI： 10.1161/CIRCULATIONAHA.116.022940

Source DB:  PubMed          Journal:  Circulation        ISSN： 0009-7322            Impact factor:   29.690


× No keyword cloud information.
  7 in total

1.  Precision Medicine.

Authors:  Jennifer E Van Eyk; Kimia Sobhani
Journal:  Circulation       Date:  2018-11-13       Impact factor: 29.690

Review 2.  Proteomics Research in Cardiovascular Medicine and Biomarker Discovery.

Authors:  Maggie P Y Lam; Peipei Ping; Elizabeth Murphy
Journal:  J Am Coll Cardiol       Date:  2016-12-27       Impact factor: 24.094

3.  Aptamer-based proteomics of serum and plasma in acquired aplastic anemia.

Authors:  Valentina Giudice; Angélique Biancotto; Zhijie Wu; Foo Cheung; Julián Candia; Giovanna Fantoni; Sachiko Kajigaya; Olga Rios; Danielle Townsley; Xingmin Feng; Neal S Young
Journal:  Exp Hematol       Date:  2018-10-09       Impact factor: 3.084

Review 4.  Proteomics and Metabolomics in Kidney Disease, including Insights into Etiology, Treatment, and Prevention.

Authors:  Ruth F Dubin; Eugene P Rhee
Journal:  Clin J Am Soc Nephrol       Date:  2019-10-21       Impact factor: 8.237

5.  Comprehensive Proteomics Profiling Identifies Patients With Late Gadolinium Enhancement on Cardiac Magnetic Resonance Imaging in the Hypertrophic Cardiomyopathy Population.

Authors:  Bradley S Lander; Yanling Zhao; Kohei Hasegawa; Mathew S Maurer; Albree Tower-Rader; Michael A Fifer; Muredach P Reilly; Yuichi J Shimada
Journal:  Front Cardiovasc Med       Date:  2022-06-17

6.  Comprehensive Proteomics Profiling Reveals Circulating Biomarkers of Hypertrophic Cardiomyopathy.

Authors:  Yuichi J Shimada; Yoshihiko Raita; Lusha W Liang; Mathew S Maurer; Kohei Hasegawa; Michael A Fifer; Muredach P Reilly
Journal:  Circ Heart Fail       Date:  2021-07-01       Impact factor: 10.447

7.  Improving Assessment of Drug Safety Through Proteomics: Early Detection and Mechanistic Characterization of the Unforeseen Harmful Effects of Torcetrapib.

Authors:  Stephen A Williams; Ashwin C Murthy; Robert K DeLisle; Craig Hyde; Anders Malarstig; Rachel Ostroff; Sophie J Weiss; Mark R Segal; Peter Ganz
Journal:  Circulation       Date:  2017-10-03       Impact factor: 29.690
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.